Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mona-Rita Yacoub

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|January 19, 2023
A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammationMatteo Trimarchi, Alessandro Vinciguerra, Andrea Rampi, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 21, 2022
Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary resultsAlessandro Vinciguerra, Andrea Rampi, Mona-Rita Yacoub, et al.
Cytometry. Part B, Clinical Cytometry|July 18, 2015
Evaluation of basophil activation test in suspected food hypersensitivityPatrizia Pignatti, Mona-Rita Yacoub, Claudia Testoni, et al.
Inflammation & Allergy Drug Targets|April 18, 2012
Effects of sublingual immunotherapy on allergic inflammation: an updateMona-Rita Yacoub, Giselda Colombo, Francesco Marcucci, et al.
Pharmaceutics|September 28, 2023
Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target TherapyDiego Bagnasco, Edoardo Vincenzo Savarino, Mona-Rita Yacoub, et al.
Drugs|June 7, 2024
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the LifespanCarlo Lombardi, Pasquale Comberiati, Erminia Ridolo, et al.
International Archives of Allergy and Immunology|April 27, 2018
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled StudyMona-Rita Yacoub, Giuseppe A Ramirez, Alvise Berti, et al.
Inflammation & Allergy Drug Targets|September 11, 2008
Effects of sublingual immunotherapy on allergic inflammationCristoforo Incorvaia, Franco Frati, Paola Puccinelli, et al.
American Journal of Respiratory and Critical Care Medicine|October 22, 2005
Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosisPatrizia Pignatti, Giuseppe Brunetti, Dania Moretto, et al.
Biomed Research International|April 6, 2018
Eosinophils from Physiology to Disease: A Comprehensive ReviewGiuseppe A Ramirez, Mona-Rita Yacoub, Marco Ripa, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|January 19, 2023
A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammationMatteo Trimarchi, Alessandro Vinciguerra, Andrea Rampi, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 21, 2022
Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary resultsAlessandro Vinciguerra, Andrea Rampi, Mona-Rita Yacoub, et al.
Cytometry. Part B, Clinical Cytometry|July 18, 2015
Evaluation of basophil activation test in suspected food hypersensitivityPatrizia Pignatti, Mona-Rita Yacoub, Claudia Testoni, et al.
Inflammation & Allergy Drug Targets|April 18, 2012
Effects of sublingual immunotherapy on allergic inflammation: an updateMona-Rita Yacoub, Giselda Colombo, Francesco Marcucci, et al.
Pharmaceutics|September 28, 2023
Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target TherapyDiego Bagnasco, Edoardo Vincenzo Savarino, Mona-Rita Yacoub, et al.
Drugs|June 7, 2024
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the LifespanCarlo Lombardi, Pasquale Comberiati, Erminia Ridolo, et al.
International Archives of Allergy and Immunology|April 27, 2018
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled StudyMona-Rita Yacoub, Giuseppe A Ramirez, Alvise Berti, et al.
Inflammation & Allergy Drug Targets|September 11, 2008
Effects of sublingual immunotherapy on allergic inflammationCristoforo Incorvaia, Franco Frati, Paola Puccinelli, et al.
American Journal of Respiratory and Critical Care Medicine|October 22, 2005
Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosisPatrizia Pignatti, Giuseppe Brunetti, Dania Moretto, et al.
Biomed Research International|April 6, 2018
Eosinophils from Physiology to Disease: A Comprehensive ReviewGiuseppe A Ramirez, Mona-Rita Yacoub, Marco Ripa, et al.
Pageof 6